chr5-140639849-G-A

Variant summary

Our verdict is Uncertain significance. The variant received 1 ACMG points: 2P and 1B. PM2BP4

The NM_018502.5(TMCO6):​c.196G>A​(p.Glu66Lys) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000138 in 1,449,570 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000014 ( 0 hom. )

Consequence

TMCO6
NM_018502.5 missense, splice_region

Scores

8
11
Splicing: ADA: 0.9102
1
1

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 2.95
Variant links:
Genes affected
TMCO6 (HGNC:28814): (transmembrane and coiled-coil domains 6) Predicted to enable nuclear import signal receptor activity. Predicted to be involved in protein import into nucleus. Predicted to be integral component of membrane. [provided by Alliance of Genome Resources, Apr 2022]
NDUFA2 (HGNC:7685): (NADH:ubiquinone oxidoreductase subunit A2) The encoded protein is a subunit of the hydrophobic protein fraction of the NADH:ubiquinone oxidoreductase (complex 1), the first enzyme complex in the electron transport chain located in the inner mitochondrial membrane, and may be involved in regulating complex I activity or its assembly via assistance in redox processes. Mutations in this gene are associated with Leigh syndrome, an early-onset progressive neurodegenerative disorder. Alternative splicing results in multiple transcript variants.[provided by RefSeq, May 2010]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 1 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.32711458).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TMCO6NM_018502.5 linkc.196G>A p.Glu66Lys missense_variant, splice_region_variant Exon 2 of 12 ENST00000394671.8 NP_060972.3 Q96DC7-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TMCO6ENST00000394671.8 linkc.196G>A p.Glu66Lys missense_variant, splice_region_variant Exon 2 of 12 2 NM_018502.5 ENSP00000378166.3 Q96DC7-1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD2 exomes
AF:
0.00000899
AC:
2
AN:
222566
AF XY:
0.00000830
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00000995
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000138
AC:
2
AN:
1449570
Hom.:
0
Cov.:
31
AF XY:
0.00000139
AC XY:
1
AN XY:
719630
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33394
American (AMR)
AF:
0.00
AC:
0
AN:
42392
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25766
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39324
South Asian (SAS)
AF:
0.0000119
AC:
1
AN:
83700
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52452
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5380
European-Non Finnish (NFE)
AF:
9.03e-7
AC:
1
AN:
1107244
Other (OTH)
AF:
0.00
AC:
0
AN:
59918
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Jun 07, 2025
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.196G>A (p.E66K) alteration is located in exon 2 (coding exon 2) of the TMCO6 gene. This alteration results from a G to A substitution at nucleotide position 196, causing the glutamic acid (E) at amino acid position 66 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.13
BayesDel_addAF
Benign
-0.20
T
BayesDel_noAF
Benign
-0.42
CADD
Pathogenic
26
DANN
Uncertain
1.0
DEOGEN2
Benign
0.021
T;.
Eigen
Uncertain
0.39
Eigen_PC
Uncertain
0.44
FATHMM_MKL
Uncertain
0.85
D
LIST_S2
Uncertain
0.87
D;D
M_CAP
Benign
0.019
T
MetaRNN
Benign
0.33
T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Uncertain
2.5
M;M
PhyloP100
2.9
PrimateAI
Uncertain
0.50
T
PROVEAN
Benign
-1.5
N;N
REVEL
Benign
0.056
Sift
Benign
0.061
T;D
Sift4G
Uncertain
0.058
T;T
Polyphen
0.94
P;P
Vest4
0.14
MutPred
0.44
Gain of MoRF binding (P = 0.0033);Gain of MoRF binding (P = 0.0033);
MVP
0.60
MPC
0.63
ClinPred
0.81
D
GERP RS
5.4
PromoterAI
0.032
Neutral
Varity_R
0.15
gMVP
0.20
Mutation Taster
=258/42
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.91
dbscSNV1_RF
Pathogenic
0.81
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1443016633; hg19: chr5-140019434; API